Wednesday, May 6, 2026

Kim Jong Un Marks ‘Day of the Shining Star’ with Visit to Kumsusan Palace

Kim Jong Un commemorated his father Kim Jong Il's birthday at Kumsusan Palace, reaffirming his commitment to North Korea's prosperity.

POINTLESS PROSECUTION: The Absurdity Of An NGO Suing A Former Diplomat And A University Professor

Gwangju City and the May 18 Memorial Foundation filed a complaint against contributors for spreading false info about the May 18 Movement.

How North Korea is Leveraging Middle East Conflict: A Strategic Shift Amidst Global Tensions

North Korea may exploit the escalating Israel-Iran conflict to enhance its foreign strategy and military posture amid U.S. distractions.

Health

Tailored Chemotherapy Boosts Survival Rates for Elderly Colon Cancer Patients

A study reveals tailored treatment for elderly colon cancer patients boosts survival rates, challenging age-based treatment limitations.

HLB Group Appoints Yang Eun-young President of Bio Business Development Division

HLB Group appoints Yang Eun-young as President of Bio Business Development, focusing on global partnerships and commercialization strategies.

VAIM Hosts JUVELOOK and juveàcell Symposium in Busan for Aesthetic Medicine and Treatment

VAIM hosted the JUVELOOK & juveàcell Symposium in Busan, showcasing advancements in aesthetic medicine for healthcare providers.

Curocell’s RIMQARTO®: The First CAR-T Therapy in Korea, with Plans for Global Release

Curocell aims to lead in CAR-T therapies with RIMQARTO's approval, focusing on solid tumors and global expansion strategies.

Qurient Mocaciclib’s CDK7 Inhibitor is Revolutionizing High-Risk Pediatric Brain Cancer Therapy

Qurient's Mocaciclib shows promising results for pediatric brain tumors, enhancing survival and overcoming treatment barriers.
Latest

Stage 3 lung cancer patients over 70 can receive “active treatment” so “should not give up”

A study shows elderly patients (70+) with stage 3 lung cancer can complete standard treatment, challenging age-related treatment hesitance.

Alzheimer’s Breakthrough: Monthly Injections of IVL3003 vs. GB-5001A—Which is More Effective?

New long-acting injectable formulations of donepezil for Alzheimer's aim to improve adherence and efficacy, easing caregiver burdens.

Breakthrough in neuroscience research…precision correction technology for microscope image distortion developed

KAIST's research team developed a software algorithm to correct microscope image distortions, enhancing biological observation without extra hardware.

ABL209: The Promising Dual Antibody ADC Revolutionizing Cancer Treatment in 2026

ABL Bio's ABL209 shows promising anti-cancer effects with broad safety in preclinical studies, advancing to Phase 1 trials in the U.S.

Celltrion’s Steqeyma IV Approval: What This Means for Celltrion’s Growth in Japan’s Autoimmune Drug Market

Celltrion's Steqeyma IV formulation gains approval in Japan, expanding treatment for Crohn's disease and enhancing market competitiveness.

KRISS Develops Innovative Toxicity Assessment System Using Water Flea Heart Rate Measurement

KRISS has developed an automated system to measure water flea heart rates for precise toxicity assessments, enhancing environmental research.

Unlocking Triple Negative Breast Cancer: How Gene-Protein Analysis Predicts Treatment Success

A study reveals that analyzing genetic and protein data can predict chemotherapy effectiveness in triple-negative breast cancer, aiding personalized treatment.

Nesuparib: The Game-Changing Cancer Treatment for Small Cell Lung Cancer Revealed at AACR 2026

Onconic Therapeutics reveals Nesuparib's promising preclinical results for small cell lung cancer, outperforming existing treatments significantly.

Revolutionary Long-Lasting Injections: How IVL3003 and IVL3004 are Transforming Dementia and Addiction Treatments

Inventage Lab will present promising results from clinical trials of two long-acting injectables at the 2026 AAN meeting in Chicago.

Coreline Soft’s SaaS Shift: How AI is Transforming Medical Imaging in Europe and Asia

Coreline Soft shifts to a SaaS model, expanding into the European market, enhancing revenue stability, and focusing on policy integration.

Is Your Health at Risk? The Dangerous Rise of Mega Pharmacies in Korea

Mega Factory Pharmacy sells cold medicines without restrictions, raising safety concerns over misuse and impacting neighborhood pharmacies.

BA.3.2 Variant: Is This the New COVID-19 Threat for Asia?

The BA.3.2 COVID-19 variant is spreading globally, prompting health authorities to urge vaccinations for high-risk individuals.

Lunit supplies integrated breast cancer diagnostic solution to Lexington Clinic

Lunit supplies integrated breast cancer AI solutions to Lexington Clinic, enhancing diagnostics and expanding its presence in the Americas.

CGBio’s DCLASSY PDRN receives clinical trial approval from MFDS

CGBio's DCLASSY PDRN skin booster gains IDE approval for clinical trials targeting eye wrinkles, enhancing patient satisfaction and market competitiveness.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.